Solara Active Pharma Sciences Ltd reports Q1FY22 consolidated net profit of Rs. 50.13 crores

SOLARA ACTIVE PHARMA SCIENCES LIMITED has reported financial results for the period ended June 30, 2021.

Financial Results (Q1 FY 2021-22) - QoQ Comparison

The company has reported total income of Rs.411.48 crores during the period ended June 30, 2021 as compared to Rs.453.99 crores during the period ended March 31, 2021.

The company has posted net profit / (loss) of Rs.50.13 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.56.65 crores for the period ended March 31, 2021.

The company has reported EPS of Rs.13.88 for the period ended June 30, 2021 as compared to Rs.15.24 for the period ended March 31, 2021.

Financials	Q1 FY2021-22	Q4 FY20-21	% Change
Total Income	₹ 411.48 crs	₹ 453.99 crs	-9.36%
Net Profit	₹ 50.13 crs	₹ 56.65 crs	-11.51%
EPS	₹ 13.88	₹ 15.24	-8.92%

Financial Results (Q1 FY 2021-22) - YoY Comparison

The company has reported total income of Rs.411.48 crores during the period ended June 30, 2021 as compared to Rs.353 crores during the period ended June 30, 2020.

The company has posted net profit / (loss) of Rs.50.13 crores for the period ended June 30, 2021 as against net profit / (loss) of Rs.42.28 crores for the period ended June 30, 2020.

The company has reported EPS of Rs.13.88 for the period ended June 30, 2021 as compared to Rs.14.74 for the period ended June 30, 2020.

Financials	Q1 FY2021-22	Q1 FY2020-21	% Change
Total Income	₹ 411.48 crs	₹ 353 crs	16.57%
Net Profit	₹ 50.13 crs	₹ 42.28 crs	18.57%
EPS	₹ 13.88	₹ 14.74	-5.83%

Shares of SOLARA ACTIVE PHARMA SCIENCES LIMITED was last trading in BSE at Rs. 1775.85 as compared to the previous close of Rs. 1732.65. The total number of shares traded during the day was 20406 in over 3317 trades.

The stock hit an intraday high of Rs. 1794.5 and intraday low of 1735. The net turnover during the day was Rs. 36144707.

Source : Equity Bulls

Keywords